BamSEC and AlphaSense Join Forces
Learn More

Vir Biotechnology Inc.

NASDAQ: VIR    
Share price (12/20/24): $7.34    
Market cap (12/20/24): $1.011 billion
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.8
from S-3ASR 8 pages Form of Subordinated Note
12/34/56
EX-4.7
from S-3ASR 8 pages Form of Senior Note
12/34/56
EX-4.6
from S-3ASR 61 pages Vir Biotechnology, Inc. and Trustee Indenture Dated as of Subordinated Debt Securities
12/34/56
EX-4.5
from S-3ASR 58 pages Vir Biotechnology, Inc. and Trustee Indenture Dated as of Senior Debt Securities
12/34/56
EX-4.11
from S-3ASR 18 pages Vir Biotechnology, Inc. and , as Warrant Agent Form of Debt Securities Warrant Agreement Dated as of Vir Biotechnology, Inc. Form of Debt Securities Warrant Agreement Article 1
12/34/56
EX-4.10
from S-3ASR 20 pages Vir Biotechnology, Inc. and , as Warrant Agent Form of Preferred Stock Warrant Agreement Dated as of Vir Biotechnology, Inc. Form of Preferred Stock Warrant Agreement Article 1 Issuance of Warrants and Execution and Delivery of Warrant Certificates
12/34/56
EX-4.9
from S-3ASR 20 pages Vir Biotechnology, Inc. and , as Warrant Agent Form of Common Stock Warrant Agreement Dated as of Vir Biotechnology, Inc. Form of Common Stock Warrant Agreement Article 1 Issuance of Warrants and Execution and Delivery of Warrant Certificates
12/34/56
EX-4.6
from S-3ASR 55 pages Vir Biotechnology, Inc., Issuer and [Trustee], Trustee Indenture Dated as of [●], 20 Debt Securities
12/34/56
EX-4.4
from 10-K 4 pages Description of Capital Stock
12/34/56
EX-4.11
from S-8 13 pages Vir Biotechnology, Inc. 2019 Employee Stock Purchase Plan
12/34/56
EX-4.8
from S-8 24 pages Vir Biotechnology, Inc. 2019 Equity Incentive Plan Adopted by the Board of Directors: September 16, 2019 Approved by the Stockholders: September 25, 2019 Ipo Date: October 10, 2019
12/34/56
EX-4.1
from S-1/A 2 pages Indenture or similar
12/34/56
EX-4.3
from S-1 15 pages Vir Biotechnology, Inc. Amended and Restated Warrant to Purchase Series A-1 Preferred Stock
12/34/56
EX-4.2
from S-1 44 pages Vir Biotechnology, Inc. Amended and Restated Investors’ Rights Agreement November 29, 2017
12/34/56
EX-4.2
from DRS 44 pages Vir Biotechnology, Inc. Amended and Restated Investors’ Rights Agreement November 29, 2017
12/34/56